Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-08-20
1985-12-10
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546220, A61K 3700, C07D21140
Patent
active
045580570
ABSTRACT:
Highly purified fractions from human urine exhibiting antineoplastic activity and processes for their preparation are described. The fractions comprise biologically active, small sized, low molecular weight peptides which exert cytostatic and cytotoxic activity toward neoplastic cell cultures and human neoplastic diseases. The fractions have been termed antineoplaston fractions. An antineoplastic active peptide common to each of the various antineoplaston fractions has been isolated and identified as 3-[N-phenylacetylaminopiperidine]-2, 6-dion. A synthetic mechanism for the preparation of 3-[N-phenylacetylaminopiperdine]-2, 6-dion is also disclosed, involving a combination reaction between L-glutamine and phenylacetyl chloride. Also disclosed are the hydrolysis degradation products of 3-[N-phenylacetylaminopiperidine]-2, 6-dion which also exhibit antineoplastic activity when administered according to the general teachings presented in this disclosure.
REFERENCES:
patent: 4470976 (1981-12-01), Burzynski
Stein, W. H. et al., "Phenylacetylglutamine as a Constituent of Normal Human Urine", J. Amer. Chem. Soc., 70:2848-9, (1954).
Burzynski, S. R. et al., "Purification, Structure Determination, Synthesis and Animal Toxicity Studies of Antineoplaston A10", 13th International Congress of Chemotherapy, (Aug.-Sep. 1983).
Antineoplastons, Unlisted Drugs, 28:133, (Aug. 1976).
Kamerling, J. P. et al., "Gas Chromatography of Urinary N-Phenylacetylglutamine", J. Chromatography, 164:217-221, (1979).
Pinkston, D., J. Chromatography, 223:1-19, (1981).
LandOfFree
Purified antineoplaston fractions and methods of treating neopla does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Purified antineoplaston fractions and methods of treating neopla, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purified antineoplaston fractions and methods of treating neopla will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-59116